Specialty Enzymes Market By Application (Pharmaceuticals, Biotechnology research and development, Diagnostics), By Source (Microorganisms, Plants, Animal), By Type (Carbohydrases, Proteases, Lipases, Polymerases & nucleases, Other enzymes): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global specialty enzymes market was valued at $1,166.1 million in 2021, and is projected to reach $2,176.0 million by 2031, registering a CAGR of 6.7% from 2022 to 2031.
Enzymes are proteins that help speed up metabolism or chemical reactions in body. Specialty enzymes have applications in various industries such as pharmaceuticals, diagnostics, and food industries. These specialty enzymes can be derived from micro-organisms, plants, and animal sources.
Rise in prevalence of chronic diseases such as cancer and rheumatoid arthritis drive growth of the market. For instance, according to the World Health Organization (WHO), cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Enzymes empower the immune system to eradicate unwanted cells on its own. Enzymes such as lipoprotein lipase (LPL), lysozyme, and asparaginase are utilized in the treatment of cancer. Thus, rise in prevalence of cancer drives growth of the market. In addition, enzymes are used for the digestive diseases and immunodeficiency disorders, which further boosts demand for specialty enzymes.
Furthermore, expansion of food industries drives demand of specialty enzymes. Enzymes such as lipases, amylases, proteases, rennet, pectinases, invertases, cellulases, and glucose oxidase play an important role in the food processing industry. For instance, according to the U.S. national institute of standards and technology (NIST), in 2021, the food and beverage industry is the third largest contributor to the overall U.S. manufacturing gross domestic product. Thus, increase in application of enzymes in the food industry and surge in expanding food processing industry drives growth of the market.
Moreover, increase in R&D activities for development of specialty enzymes, rise in clinical trials for medicinal application of enzymes, and novel product launches in the market by key players boost the market growth. For instance, Jazz Pharmaceuticals plc, a leading biologics company, announced positive results from a Phase 2/3 trial, developed and conducted in close collaboration with the Children's Oncology Group (COG), evaluating the intramuscular (IM) administration of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) in adult and pediatric patients with acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) who have developed hypersensitivity to an E. coli-derived asparaginase. However, complexities developed in biosimilars hinder growth of the market.
The specialty enzymes market is segmented on the basis of application, source, type, and region. By application, the market is classified into pharmaceuticals, biotechnology research & development, and diagnostics. On the basis of source, it is divided into microorganisms, plants, and animals. By type, it is divided into carbohydrase, proteases, lipases, polymerases & nucleases, and other enzymes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Alphazyme LLC, Amano Enzyme, Antozyme Biotech, Enzyme Development Corporation, BBI Solution, Biocatalyst, Novoenzymes, Specialty Enzymes and Probiotics, International Flavors and Fragrances Inc., and Enzyme Supplies Ltd.
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis along with the current specialty enzymes market trends from 2022 to 2031 to identify the prevailing opportunities along with the strategic assessment.
The specialty enzymes market forecast is studied from 2022 to 2031.
The market size and estimations are based on a comprehensive analysis of key developments in the specialty enzymes industry.
A qualitative analysis based on innovative products facilitates strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the specialty enzymes market.
Key Market Segments
By Application
Pharmaceuticals
Biotechnology research and development
Diagnostics
By Source
Microorganisms
Plants
Animal
By Type
Carbohydrases
Proteases
Lipases
Polymerases nucleases
Other enzymes
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest Of Asia Pacific
LAMEA
Brazil
Turkey
South Africa
Rest of LAMEA
Key Market Players
Antozyme Biotech
Enzyme Development Corporation
BBI Solutions
Biocatalyst
Novozymes
Specialty Enzyme and Probiotics
International Flavor & Fragrance Inc
Enzyme Supplies Limited
Alphazyme LLC
Amano Enzyme
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: SPECIALTY ENZYMES MARKET, BY APPLICATION
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Pharmaceuticals
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Biotechnology research and development
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Diagnostics
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- CHAPTER 5: SPECIALTY ENZYMES MARKET, BY SOURCE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Microorganisms
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Plants
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Animal
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: SPECIALTY ENZYMES MARKET, BY TYPE
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Carbohydrases
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Proteases
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Lipases
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- 6.5 Polymerases & nucleases
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
- 6.6 Other enzymes
- 6.6.1 Key market trends, growth factors and opportunities
- 6.6.2 Market size and forecast, by region
- 6.6.3 Market analysis by country
- CHAPTER 7: SPECIALTY ENZYMES MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Application
- 7.2.3 North America Market size and forecast, by Source
- 7.2.4 North America Market size and forecast, by Type
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Application
- 7.2.5.1.2 Market size and forecast, by Source
- 7.2.5.1.3 Market size and forecast, by Type
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Application
- 7.2.5.2.2 Market size and forecast, by Source
- 7.2.5.2.3 Market size and forecast, by Type
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Application
- 7.2.5.3.2 Market size and forecast, by Source
- 7.2.5.3.3 Market size and forecast, by Type
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Application
- 7.3.3 Europe Market size and forecast, by Source
- 7.3.4 Europe Market size and forecast, by Type
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Application
- 7.3.5.1.2 Market size and forecast, by Source
- 7.3.5.1.3 Market size and forecast, by Type
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Application
- 7.3.5.2.2 Market size and forecast, by Source
- 7.3.5.2.3 Market size and forecast, by Type
- 7.3.5.3 United Kingdom
- 7.3.5.3.1 Market size and forecast, by Application
- 7.3.5.3.2 Market size and forecast, by Source
- 7.3.5.3.3 Market size and forecast, by Type
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Application
- 7.3.5.4.2 Market size and forecast, by Source
- 7.3.5.4.3 Market size and forecast, by Type
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Application
- 7.3.5.5.2 Market size and forecast, by Source
- 7.3.5.5.3 Market size and forecast, by Type
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Application
- 7.3.5.6.2 Market size and forecast, by Source
- 7.3.5.6.3 Market size and forecast, by Type
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Application
- 7.4.3 Asia-Pacific Market size and forecast, by Source
- 7.4.4 Asia-Pacific Market size and forecast, by Type
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Application
- 7.4.5.1.2 Market size and forecast, by Source
- 7.4.5.1.3 Market size and forecast, by Type
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Application
- 7.4.5.2.2 Market size and forecast, by Source
- 7.4.5.2.3 Market size and forecast, by Type
- 7.4.5.3 Australia
- 7.4.5.3.1 Market size and forecast, by Application
- 7.4.5.3.2 Market size and forecast, by Source
- 7.4.5.3.3 Market size and forecast, by Type
- 7.4.5.4 India
- 7.4.5.4.1 Market size and forecast, by Application
- 7.4.5.4.2 Market size and forecast, by Source
- 7.4.5.4.3 Market size and forecast, by Type
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Application
- 7.4.5.5.2 Market size and forecast, by Source
- 7.4.5.5.3 Market size and forecast, by Type
- 7.4.5.6 Rest Of Asia Pacific
- 7.4.5.6.1 Market size and forecast, by Application
- 7.4.5.6.2 Market size and forecast, by Source
- 7.4.5.6.3 Market size and forecast, by Type
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Application
- 7.5.3 LAMEA Market size and forecast, by Source
- 7.5.4 LAMEA Market size and forecast, by Type
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Application
- 7.5.5.1.2 Market size and forecast, by Source
- 7.5.5.1.3 Market size and forecast, by Type
- 7.5.5.2 Turkey
- 7.5.5.2.1 Market size and forecast, by Application
- 7.5.5.2.2 Market size and forecast, by Source
- 7.5.5.2.3 Market size and forecast, by Type
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Application
- 7.5.5.3.2 Market size and forecast, by Source
- 7.5.5.3.3 Market size and forecast, by Type
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Application
- 7.5.5.4.2 Market size and forecast, by Source
- 7.5.5.4.3 Market size and forecast, by Type
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Antozyme Biotech
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Enzyme Development Corporation
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 BBI Solutions
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Biocatalyst
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Novozymes
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Specialty Enzyme and Probiotics
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 International Flavor & Fragrance Inc
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Enzyme Supplies Limited
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Alphazyme LLC
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Amano Enzyme
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 2. SPECIALTY ENZYMES MARKET SIZE, FOR PHARMACEUTICALS, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. SPECIALTY ENZYMES MARKET FOR PHARMACEUTICALS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. SPECIALTY ENZYMES MARKET SIZE, FOR BIOTECHNOLOGY RESEARCH AND DEVELOPMENT, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. SPECIALTY ENZYMES MARKET FOR BIOTECHNOLOGY RESEARCH AND DEVELOPMENT BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. SPECIALTY ENZYMES MARKET SIZE, FOR DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. SPECIALTY ENZYMES MARKET FOR DIAGNOSTICS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 8. GLOBAL SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 9. SPECIALTY ENZYMES MARKET SIZE, FOR MICROORGANISMS, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. SPECIALTY ENZYMES MARKET FOR MICROORGANISMS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. SPECIALTY ENZYMES MARKET SIZE, FOR PLANTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. SPECIALTY ENZYMES MARKET FOR PLANTS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 13. SPECIALTY ENZYMES MARKET SIZE, FOR ANIMAL, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. SPECIALTY ENZYMES MARKET FOR ANIMAL BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 15. GLOBAL SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 16. SPECIALTY ENZYMES MARKET SIZE, FOR CARBOHYDRASES, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. SPECIALTY ENZYMES MARKET FOR CARBOHYDRASES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. SPECIALTY ENZYMES MARKET SIZE, FOR PROTEASES, BY REGION, 2021-2031 ($MILLION)
- TABLE 19. SPECIALTY ENZYMES MARKET FOR PROTEASES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 20. SPECIALTY ENZYMES MARKET SIZE, FOR LIPASES, BY REGION, 2021-2031 ($MILLION)
- TABLE 21. SPECIALTY ENZYMES MARKET FOR LIPASES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 22. SPECIALTY ENZYMES MARKET SIZE, FOR POLYMERASES & NUCLEASES, BY REGION, 2021-2031 ($MILLION)
- TABLE 23. SPECIALTY ENZYMES MARKET FOR POLYMERASES & NUCLEASES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 24. SPECIALTY ENZYMES MARKET SIZE, FOR OTHER ENZYMES, BY REGION, 2021-2031 ($MILLION)
- TABLE 25. SPECIALTY ENZYMES MARKET FOR OTHER ENZYMES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 26. SPECIALTY ENZYMES MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 27. NORTH AMERICA SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 28. NORTH AMERICA SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 29. NORTH AMERICA SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 30. NORTH AMERICA SPECIALTY ENZYMES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 31. U.S. SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 32. U.S. SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 33. U.S. SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 34. CANADA SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 35. CANADA SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 36. CANADA SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 37. MEXICO SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 38. MEXICO SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 39. MEXICO SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 40. EUROPE SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 41. EUROPE SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 42. EUROPE SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 43. EUROPE SPECIALTY ENZYMES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 44. GERMANY SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 45. GERMANY SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 46. GERMANY SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 47. FRANCE SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 48. FRANCE SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 49. FRANCE SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 50. UNITED KINGDOM SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 51. UNITED KINGDOM SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 52. UNITED KINGDOM SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 53. ITALY SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 54. ITALY SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 55. ITALY SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 56. SPAIN SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 57. SPAIN SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 58. SPAIN SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 59. REST OF EUROPE SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 60. REST OF EUROPE SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 61. REST OF EUROPE SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 62. ASIA-PACIFIC SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 63. ASIA-PACIFIC SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 64. ASIA-PACIFIC SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 65. ASIA-PACIFIC SPECIALTY ENZYMES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 66. JAPAN SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 67. JAPAN SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 68. JAPAN SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 69. CHINA SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 70. CHINA SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 71. CHINA SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 72. AUSTRALIA SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 73. AUSTRALIA SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 74. AUSTRALIA SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 75. INDIA SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 76. INDIA SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 77. INDIA SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 78. SOUTH KOREA SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 79. SOUTH KOREA SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 80. SOUTH KOREA SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 81. REST OF ASIA PACIFIC SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 82. REST OF ASIA PACIFIC SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 83. REST OF ASIA PACIFIC SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 84. LAMEA SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 85. LAMEA SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 86. LAMEA SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 87. LAMEA SPECIALTY ENZYMES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 88. BRAZIL SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 89. BRAZIL SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 90. BRAZIL SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 91. TURKEY SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 92. TURKEY SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 93. TURKEY SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 94. SOUTH AFRICA SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 95. SOUTH AFRICA SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 96. SOUTH AFRICA SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 97. REST OF LAMEA SPECIALTY ENZYMES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 98. REST OF LAMEA SPECIALTY ENZYMES MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 99. REST OF LAMEA SPECIALTY ENZYMES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 100.ANTOZYME BIOTECH: COMPANY SNAPSHOT
- TABLE 101.ANTOZYME BIOTECH: OPERATING SEGMENTS
- TABLE 102.ANTOZYME BIOTECH: PRODUCT PORTFOLIO
- TABLE 103.ANTOZYME BIOTECH: NET SALES,
- TABLE 104.ANTOZYME BIOTECH: KEY STRATERGIES
- TABLE 105.ENZYME DEVELOPMENT CORPORATION: COMPANY SNAPSHOT
- TABLE 106.ENZYME DEVELOPMENT CORPORATION: OPERATING SEGMENTS
- TABLE 107.ENZYME DEVELOPMENT CORPORATION: PRODUCT PORTFOLIO
- TABLE 108.ENZYME DEVELOPMENT CORPORATION: NET SALES,
- TABLE 109.ENZYME DEVELOPMENT CORPORATION: KEY STRATERGIES
- TABLE 110.BBI SOLUTIONS: COMPANY SNAPSHOT
- TABLE 111.BBI SOLUTIONS: OPERATING SEGMENTS
- TABLE 112.BBI SOLUTIONS: PRODUCT PORTFOLIO
- TABLE 113.BBI SOLUTIONS: NET SALES,
- TABLE 114.BBI SOLUTIONS: KEY STRATERGIES
- TABLE 115.BIOCATALYST: COMPANY SNAPSHOT
- TABLE 116.BIOCATALYST: OPERATING SEGMENTS
- TABLE 117.BIOCATALYST: PRODUCT PORTFOLIO
- TABLE 118.BIOCATALYST: NET SALES,
- TABLE 119.BIOCATALYST: KEY STRATERGIES
- TABLE 120.NOVOZYMES: COMPANY SNAPSHOT
- TABLE 121.NOVOZYMES: OPERATING SEGMENTS
- TABLE 122.NOVOZYMES: PRODUCT PORTFOLIO
- TABLE 123.NOVOZYMES: NET SALES,
- TABLE 124.NOVOZYMES: KEY STRATERGIES
- TABLE 125.SPECIALTY ENZYME AND PROBIOTICS: COMPANY SNAPSHOT
- TABLE 126.SPECIALTY ENZYME AND PROBIOTICS: OPERATING SEGMENTS
- TABLE 127.SPECIALTY ENZYME AND PROBIOTICS: PRODUCT PORTFOLIO
- TABLE 128.SPECIALTY ENZYME AND PROBIOTICS: NET SALES,
- TABLE 129.SPECIALTY ENZYME AND PROBIOTICS: KEY STRATERGIES
- TABLE 130.INTERNATIONAL FLAVOR & FRAGRANCE INC: COMPANY SNAPSHOT
- TABLE 131.INTERNATIONAL FLAVOR & FRAGRANCE INC: OPERATING SEGMENTS
- TABLE 132.INTERNATIONAL FLAVOR & FRAGRANCE INC: PRODUCT PORTFOLIO
- TABLE 133.INTERNATIONAL FLAVOR & FRAGRANCE INC: NET SALES,
- TABLE 134.INTERNATIONAL FLAVOR & FRAGRANCE INC: KEY STRATERGIES
- TABLE 135.ENZYME SUPPLIES LIMITED: COMPANY SNAPSHOT
- TABLE 136.ENZYME SUPPLIES LIMITED: OPERATING SEGMENTS
- TABLE 137.ENZYME SUPPLIES LIMITED: PRODUCT PORTFOLIO
- TABLE 138.ENZYME SUPPLIES LIMITED: NET SALES,
- TABLE 139.ENZYME SUPPLIES LIMITED: KEY STRATERGIES
- TABLE 140.ALPHAZYME LLC: COMPANY SNAPSHOT
- TABLE 141.ALPHAZYME LLC: OPERATING SEGMENTS
- TABLE 142.ALPHAZYME LLC: PRODUCT PORTFOLIO
- TABLE 143.ALPHAZYME LLC: NET SALES,
- TABLE 144.ALPHAZYME LLC: KEY STRATERGIES
- TABLE 145.AMANO ENZYME: COMPANY SNAPSHOT
- TABLE 146.AMANO ENZYME: OPERATING SEGMENTS
- TABLE 147.AMANO ENZYME: PRODUCT PORTFOLIO
- TABLE 148.AMANO ENZYME: NET SALES,
- TABLE 149.AMANO ENZYME: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.SPECIALTY ENZYMES MARKET SEGMENTATION
- FIGURE 2.SPECIALTY ENZYMES MARKET,2021-2031
- FIGURE 3.SPECIALTY ENZYMES MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.SPECIALTY ENZYMES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.SPECIALTY ENZYMES MARKET,BY APPLICATION,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICALS SPECIALTY ENZYMES MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF BIOTECHNOLOGY RESEARCH AND DEVELOPMENT SPECIALTY ENZYMES MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTICS SPECIALTY ENZYMES MARKET,2021-2031(%)
- FIGURE 16.SPECIALTY ENZYMES MARKET,BY SOURCE,2021(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MICROORGANISMS SPECIALTY ENZYMES MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF PLANTS SPECIALTY ENZYMES MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ANIMAL SPECIALTY ENZYMES MARKET,2021-2031(%)
- FIGURE 20.SPECIALTY ENZYMES MARKET,BY TYPE,2021(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF CARBOHYDRASES SPECIALTY ENZYMES MARKET,2021-2031(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PROTEASES SPECIALTY ENZYMES MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF LIPASES SPECIALTY ENZYMES MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF POLYMERASES & NUCLEASES SPECIALTY ENZYMES MARKET,2021-2031(%)
- FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHER ENZYMES SPECIALTY ENZYMES MARKET,2021-2031(%)
- FIGURE 26.SPECIALTY ENZYMES MARKET BY REGION,2021
- FIGURE 27.U.S. SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 28.CANADA SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 29.MEXICO SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 30.GERMANY SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 31.FRANCE SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 32.UNITED KINGDOM SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 33.ITALY SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 34.SPAIN SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 35.REST OF EUROPE SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 36.JAPAN SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 37.CHINA SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 38.AUSTRALIA SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 39.INDIA SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 40.SOUTH KOREA SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 41.REST OF ASIA PACIFIC SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 42.BRAZIL SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 43.TURKEY SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 44.SOUTH AFRICA SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 45.REST OF LAMEA SPECIALTY ENZYMES MARKET,2021-2031($MILLION)
- FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 50.COMPETITIVE DASHBOARD
- FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 52.ANTOZYME BIOTECH.: NET SALES ,($MILLION)
- FIGURE 53.ENZYME DEVELOPMENT CORPORATION.: NET SALES ,($MILLION)
- FIGURE 54.BBI SOLUTIONS.: NET SALES ,($MILLION)
- FIGURE 55.BIOCATALYST.: NET SALES ,($MILLION)
- FIGURE 56.NOVOZYMES.: NET SALES ,($MILLION)
- FIGURE 57.SPECIALTY ENZYME AND PROBIOTICS.: NET SALES ,($MILLION)
- FIGURE 58.INTERNATIONAL FLAVOR & FRAGRANCE INC.: NET SALES ,($MILLION)
- FIGURE 59.ENZYME SUPPLIES LIMITED.: NET SALES ,($MILLION)
- FIGURE 60.ALPHAZYME LLC.: NET SALES ,($MILLION)
- FIGURE 61.AMANO ENZYME.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook